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a  b  s  t  r  a  c  t
Mitochondrial  Hsp70  is involved  in both  protein  import  and  folding  process,  among  other  essential  func-
tions.  In  mammalian  cells,  due  to  its role  in  the malignant  process,  it receives  the  name  of  mortalin.
Despite  its importance  in  protein  and  mitochondrial  homeostasis,  mortalin  tends to  self-aggregate  in vitro
and in  vivo,  the  later leads  to  mitochondrial  biogenesis  failure.  Recently,  a zinc-ﬁnger  protein,  named
Hsp70-escort  protein  1  (Hep1,  also  called  Zim17/TIM15/DNLZ),  was  described  as  an  essential  human
mitochondrial  mortalin  co-chaperone  which  avoids  its self-aggregation.  Here,  we  report  structural  stud-
ies of the  human  Hep1  (hHep1).  The  results  indicate  that  hHep1  shares  some  structural  similarities  with
the yeast  ortholog  despite  the  low  identity  and  functional  differences.  We  also  observed  that  hHep1
oligomerizes  in  a concentration-dependent  fashion  and  that  the  zinc  ion,  which  is essential  for  hHep1  in
vivo  function,  has  an  important  protein-structure  stabilizing  effect.
© 2013 Elsevier B.V. 
1. Introduction
The majority of the mitochondrial proteins are encoded by the
nuclear genome, translated by cytosolic ribosomes as preproteins
containing peptide signals, leading to its translocation into the
mitochondria [1–4]. Therefore, the machineries of import and sor-
ting proteins into mitochondria are consequential in the biogenesis,
maintaining suitable mitochondrial functions. For that, mitochon-
drial molecular chaperones, coordinated by the mitochondrial
Hsp70 (mtHsp70), perform a critical role in the mitochondrial
import system of matrix proteins. Mitochondrial Hsp70 works as a
motor import that drives the preprotein import process and helps
the fate and folding of these proteins [4,5]. Similar to cytosolic
Hsp70, mtHsp70 presents an N-terminal ATPase domain (NBD) and
Abbreviations: AUC, analytical ultracentrifugation; CD, circular dichroism; DSC,
differential scanning calorimetry; f/f0, frictional ratio; MM,  molecular mass; Rs,
Stokes radius; Rg, radius of gyration; SAXS, small angle X-ray scattering; s20,w,
sedimentation coefﬁcient at standard conditions; s020,w, standard sedimentation
coefﬁcient at 0 mg  mL−1 of protein; [], residual molar ellipticity; 〈〉, spectral center
of mass.
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a C-terminal substrate binding domain (SBD), which are controlled
by a reciprocal allosteric mechanism [6].
Mammalian mtHsp70 is also called mortalin due to its activ-
ity in senescence and cellular death [7].  Mortalin is involved in
several cellular process and may  play key roles in Parkinson’s and
Alzheimer’s diseases [7,8], and some cancers [9,10].  Mortalin inter-
acts and kidnaps the wild type p53 in the cytoplasm reducing its
transcriptional activity, since mortalin is not an exclusively mito-
chondrial protein [7,11,12]. Although mortalin has been known for
a long time, its structural study is limited due to a self aggregation
process when it is produced heterologously [4,13,14]. Aggregation
of mtHsp70 leads to defects in protein import into mitochondria
and subsequent TIM23 dependent biogenesis failure [13]. Recently,
a new mitochondrial Hsp70 co-chaperone was  described as Hsp70-
escort protein (Hep1 – Zim17/TIM15/DNLZ), given that it has a
dual role in mtHsp70: (1) preventing its self-aggregation and (2)
controlling its ATPase activity [14,15].
Hep1 is essential for mitochondrial import machinery located
in the mitochondria matrix [14,16,17].  The deletion of yeast Hep1
(yHep1) leads to defective import of preproteins dependent on
TIM23 complex, which is also required for yeast growth at elevated
temperature [14]. However, since Hep1 acts protecting mtHsp70
from aggregation, the defective effects of yHep1 deletion on
protein import by mitochondria could be due to mtHsp70 malfunc-
tion/aggregation, and not directly linked to Hep1 activity [4,13,14].
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In yeast, Hep1 binds speciﬁcally to the NBD of mtHsp70 preven-
ting its self-aggregation in a substoichiometric way [14,18,19],  but
it may  need the interdomain linker of mtHsp70 to properly bind
[20].
Hep1 contains a zinc-ﬁnger domain which is critical for its in
vivo function, in both yeast and human cells [17,21].  The nuclear
magnetic resonance (NMR) structure of yHep1 shows an L-shape
where the zinc-ﬁnger cluster is quite buried and forms the major
leg, and two small -helices form the other leg of unknown function
[22]. Deletion or modiﬁcations of the zinc ﬁnger motif of human
Hep1 (hHep1) leads to defects in the aggregation avoidance action
of mortalin, suggesting that the zinc-ﬁnger cluster of hHep1 is also
essential for its interaction with mortalin [21].
Although hHep1 can supplement in vivo yHep1 deletion [21],
these proteins are not functionally equivalent. It was shown that
hHep1 increases human mortalin ATPase activity [15,18,19,21],
however this activity was not observed in yHep1 [14]. It was also
reported that hHep1 interacts with the helical lid of mortalin and
also with the NBD, which stimulates the ATPase activity of mortalin
in a mutually exclusive manner with Hsp40 proteins [15]. Interest-
ingly, yHep1 prevents human mortalin aggregation, suggesting that
the mechanism of action of Hep1 is conserved in these proteins
[18]. Besides, there are evidences that hHep1 presents intrinsic
chaperone activity [15].
In this study, we characterized the structure and stability of
hHep1 using biophysical tolls. First of all, recombinant hHep1 pre-
vented recombinant human mortalin aggregation in a coexpression
system. Human Hep1 was puriﬁed folded and behaved mainly as an
asymmetric monomer, but it also oligomerized in a concentration
dependent manner. Disturbing the hHep1 structure in the presence
and absence of the EDTA, we demonstrate that the zinc ion of the
zinc-ﬁnger domain, which is essential for hHep1 in vivo function
[17], plays a stabilizing role in the hHep1 structure.
2. Material and methods
2.1. Cloning, expression and puriﬁcation
The EST clone (dbEST Id: 14322301) was obtained from the
IMAGE consortium and was used as template for ampliﬁcation of
hHep1 DNA coding (Genbank accession number NP 001074318.1).
We used a speciﬁc forward primer (5′-ATTCATATGAGCTCCGAGC-
AGGGGCCG-3′) to amplify hHep1 DNA and to create a restriction
site for Nde I downstream of the mitochondrial peptide signal
(sequence Met1-Ser49 predicted by the MITOPROT program [23]).
This strategy eliminated the peptide signal of the recombinant pro-
tein. The T7 primer, which anneals in the pOTB7 vector, was  used
as reverse primer. Using the Nde I and Kpn I restriction enzymes,
the hHep1 DNA was inserted into pQE2 expression vector (Qia-
gen), resulting in the vector pQE2::hHep1 which codiﬁes hHep1
containing a His-tag sequence (MKHHHHHHH) at the N-terminal
of the protein.
Human mortalin was cloned from the EST clone (dbEST Id:
6195001) using the forward (5′TATGCATCACATATGATCAAGGG-
AGC3′) and reverse primer (5′ATTTCTGGGATCCTTACTGTTTTCC3′)
containing restriction sites for Nde I and BamH I, respectively. The
forward primer of the mortalin was designed to eliminate the mito-
chondrial peptide signal (sequence Met1-Ala47 also predicted by
the MITOPROT program [23]). The DNA insert was cloned into
pET28a expression vector generating the vector pET28a::Mortalin
also able to express mortalin fused to a His-tag sequence. The
cloning processes were conﬁrmed by DNA sequencing.
The recombinant proteins were expressed in Escherichia coli
BL21(DE3) strain. Summarily, cells transformed with pQE2::hHep1
were grown at 37 ◦C in LB medium, containing ampicillin
35 g mL−1, to an OD600nm (optical diffraction at 600 nm) of 0.5
where the protein expression was induced by 0.2 mM of isopropyl
thio--d-galactoside (IPTG) at 30 ◦C. After 4 h of induction, the cells
were harvested by centrifugation at 2600 × g for 10 min. Mortalin
was expressed in E. coli BL21(DE3) strain in LB medium contain-
ing kanamycin 35 g mL−1, to an OD600nm of 0.5 where the protein
expression was induced by 0.2 mM of IPTG. After 18 h of induction
at 23 ◦C, the cells were harvested by centrifugation at 2600 g for
10 min. Mortalin and hHep1 coexpression assays were performed
in E. coli BL21(DE3) strain in LB medium containing both ampicillin
and kanamycin at 35 g mL−1. The cells were grown at 37 ◦C until an
OD600nm of 0.5, at which time the temperature was  reduced to 23 ◦C,
and IPTG was  added to a ﬁnal concentration of 0.2 mM.  The cells
were incubated for 18 h at 200 rpm, harvested by centrifugation at
2600 × g and stored at −20 ◦C.
For cell lyses, the induced pellet was suspended in 50 mM
Tris–HCl (pH 8.0), 100 mM KCl and incubated with 30 g mL−1 of
lysozyme (Sigma) and 5 U of DNAse (Promega) on ice for 30 min. The
pellet was  disrupted by sonication and centrifuged at 20,000 × g for
30 min  at 4 ◦C. The supernatant was submitted to a nickel afﬁnity
chromatography in a HisTrap column (GE Healthcare Life Sciences)
and further puriﬁcation was performed in a Superdex 200 pg col-
umn  (GE Healthcare Life Sciences), both coupled to an ÄKTA Prime
system (GE Healthcare Life Sciences) in TKP buffer (25 mM Tris–HCl,
pH 7.5, 50 mM  NaCl, 5 mM sodium phosphate, 5 mM KCl and 2 mM
-mercaptoethanol). The expression and puriﬁcation processes
efﬁcacy were checked by SDS-PAGE. The protein concentration was
determined spectrophotometrically, using the calculated extinc-
tion coefﬁcient for native conditions.
2.2. Homology molecular modeling
The hHep1 (Gly62-Ala160) structure was  modeled with
homology-modeling using the Swiss Model server [24]. The solu-
tion structure of the truncated yHep1 solved by NMR  (PDB
accession no 2E2Z) was used as template.
2.3. Spectroscopy studies
Circular dichroism (CD) measurements were performed in a
Jasco J-810 spectropolarimeter. Human Hep1 was tested in TKP, at
ﬁnal concentrations ranging between 20 and 70 M in the absence
and presence of 2 mM EDTA, using a circular 0.2 mm pathlength
cuvette. The spectra were normalized to residual molar ellipticity
([]) and the protein secondary structure content was  estimated
by the CDNN Deconvolution program [25].
Intrinsic ﬂuorescence emission measurements were performed
in an F-4500 ﬂuorescence spectrophotometer (Hitachi), using a
10 mm × 2 mm pathlength cell with hHep1 in TKP buffer, at 20 ◦C.
The ﬂuorescence emission spectra were measured from 300 to
420 nm,  after excitation at 280 nm,  at hHep1 concentrations (as
a monomer) ranging between 5 and 350 M (74–5200 g mL−1).
Experiments in the absence and presence of increasing con-
centrations of urea or guanidine-hydrochloride (Gnd-HCl) were
performed with hHep1 concentration of 15 M.  The urea and Gnd-
HCl solutions were prepared in TKP buffer. The chemical-induced
unfolding was  also performed in the presence of 2 mM EDTA after
60–120 min  equilibrium time, at 20 ◦C. The data were analyzed by
maximum ﬂuorescence emission wavelength (max) and spectral
center of mass (〈〉), as described by the equation below:
〈〉 =
∑
iFi∑
Fi
(1)
where i represents each wavelength observed and Fi represents
the ﬂuorescence intensity at each wavelength. The urea induced
142 P.R. Dores-Silva et al. / International Journal of Biological Macromolecules 56 (2013) 140– 148
unfolding curves were ﬁtted with a Double-Boltzmann Function,
available in the Origin program (Microcal), in order to obtain the
concentration at the midpoint of the urea-induced unfolding tran-
sition – Cm,
2.4. Hydrodynamic characterization
The Superdex 200 GL 10/30 column (GE Healthcare Life Sci-
ences), coupled to an ÄKTA Prime system, was used to carry
out analytical size exclusion chromatography (aSEC) experiments.
hHep1 samples at several protein concentrations were applied onto
the column previously washed with TKP buffer. The column was
calibrated with standard protein mixture (at ∼1 mg  mL−1) of known
Stokes radii (Rs): apoferritin (67 A˚); -globulin (48 A˚), bovine serum
albumin (36 A˚), ovalbumin (30 A˚), carbonic anhydrase (24 A˚) and
cytochrome c (14 A˚). The retention times were transformed in the
partial coefﬁcient kav applying the following equation:
kav = Ve − V0Vt − V0
(2)
where Ve is the elution volume of the protein; V0 is the void volume
of the column and the Vt is the total volume of the column. The
−log kav was plotted against the Rs in order to estimate the Rs of
hHep1 by linear regression.
Analytical ultracentrifugation (AUC) experiments were per-
formed in a Beckman Optima XL-A analytical ultracentrifuge.
Sedimentation velocity experiments for hHep1 were carried out
in concentrations of 150–2500 g mL−1 in TKP buffer, at 20 ◦C,
35,000 rpm (AN-60Ti rotor), and data acquisition at 236 nm
(low concentrations) and 277 nm (high concentrations). The
absorbance versus cell radius data were ﬁtted by the soft-
ware SedFit (Version 12.1) [26]. As a regularization parameter,
the frictional ratio (f/f0) was allowed to ﬂoat freely. The sed-
imentation coefﬁcients were obtained as the maximum of the
peaks of the c(S) curves and converted to standard condi-
tions (s20,w) [27]. The TKP buffer viscosity ( = 1.0145 × 10−2
poise), density ( = 1.00183 g mL−1) and partial-speciﬁc volume
(Vbar = 0.7230 mL  g−1) were estimated by the Sednterp program
(http://www.jphilo.mailway.com/download.htm). With the s20,w-
value at each protein concentration the standard sedimentation
coefﬁcient was estimated at 0 mg  mL−1 of protein concentration
(s020,w) by linear regression [27]. The f/f0 can also be estimated by
the ratio of the experimental Rs to the radius of a sphere of the same
mass, or by the ratio of the sedimentation coefﬁcient of a sphere of
the same mass to the experimental one [27].
2.5. Small angle X-ray scattering experiments
Small angle X-ray scattering (SAXS) experiments were per-
formed in the Laboratório Nacional de Luz Síncrotron (LNLS,
Campinas-SP, Brazil) using a monochromatic X-ray beam (wave-
length of  = 1.488 A˚) of the D02A-SAXS2 beamline. The sample-
to-detector distance was of ∼1000 mm,  which corresponds to the
scattering vector range of 0.015 < q < 0.35 A˚−1, where q is the mag-
nitude of the q-vector deﬁned by q = (4/)sin (with 2 as the
scattering angle). Human Hep1 samples were placed in a 1-mm
path length cell formed by two mica windows, and the scat-
tering curves were recorded at different sample concentrations
(1.7–8.6 mg  mL−1) solved in TKP buffer. Samples and buffers were
submitted to X-ray frames of 300 s. The scattering curves were
corrected for detector response and scaled by the incident beam
and attenuated intensity of the sample. The corrected sample
scattering was subtracted from the buffer scattering curve. All
intensities are in absolute scale, cm−1, such calibration was estab-
lished from the scattered intensity of pure water, which depends on
the isothermal compressibility and on its electron density (I(0)water,
293 K = 0.01632 cm−1) [28]. The I(0) value is related to the protein
concentration as well as to MM and consequently to the protein
aggregation state. Thus the I(0)/cprot (where cprot is the protein con-
centration) and the protein radius of gyration, Rg, can give useful
information on the protein aggregation state [29]. The urea effect
on the hHep1 (at 3.5 mg  mL−1) structure was also checked by SAXS
in the absence and presence of 2 mM EDTA, measuring samples
composed of 0 and 6 M of urea. All scattering curves were carefully
corrected by the urea-containing buffer.
2.6. Differential scanning calorimetry
Differential scanning calorimetry (DSC) measurements of
thermal-induced unfolding were performed in a Nano DSC (TA
Instruments). The measurements were performed at 1.5 mg  mL−1
solved in TKP buffer after extensive dialysis. The scan rate tested
was of 1.0 ◦C min−1 at the 20–90 ◦C temperature range. The
reversibility of thermal unfolding was  tested by performing several
consecutive up/down scans. The experimental thermograms were
collected with DSCrun software (TA Instruments) and analyzed
using the NanoAnalyze software (TA Instruments). The baselines
were calculated from the pre- and post-transition temperature
regions.
3. Results and discussion
3.1. Recombinant human mortalin aggregation is prevented by
hHep1 coexpression
The hHep1 DNA coding (gi|124249391) was  cloned into the
pQE2 expression vector without the corresponding mitochondrial
peptide signal sequence. Therefore, hHep1 construction consists
of the Ser50-Ser178 amino acid sequence (Fig. S1–supplementary
material). The recombinant hHep1 was expressed in high levels and
partially soluble after cell lysis (Fig. 1A). The recombinant protein
was puriﬁed by 2 chromatographic steps (see Section 2 for details),
thereby obtaining high purity hHep1 (lane 7 – Fig. 1A).
The functionality of the recombinant hHep1 was analyzed for
its ability to maintain recombinant human mortalin solubility in
a coexpression system. Fig. 1B shows the expression of recom-
binant human mortalin in the absence of hHep1, which yielded
the protein in the insoluble fraction of lysed cells and a minor
part in the supernatant (Fig. 1B – comparison on lanes 3, 4 and 5,
respectively). When mortalin and hHep1 were coexpressed, mor-
talin was found in much of the supernatant of the lysed cells (Fig. 1B
– comparison of lanes 7, 8 and 9, respectively). This functional
result suggests that hHep1 solubilized the recombinant human
mortalin, as was  previously shown [14,18,19,21],  allowing the pro-
duction and puriﬁcation of mortalin in the monomeric state (data
not shown).
3.2. Recombinant hHep1 was produced folded
The secondary structure content of hHep1 was studied by
CD spectropolarimetry (Fig. 1C). As observed for the zinc-ﬁnger
domain truncations of hHep1 [21], hHep1 presented CD spectra
with a minima signal at 207 nm and a shoulder at 220 nm.  The
secondary structure estimation performed by the CDNN Decon-
volution software [25] suggested that hHep1 is formed by 10% of
-helices, 34% of -sheet and 21% and 35% of turns and random
coils, respectively. The solution structure of the truncated yHep1,
solved by NMR, suggests that the secondary content is of about
23% and 28% of -helices and -sheets, respectively, with similar
CD spectra [22]. Based on these data, we  can conclude that hHep1 is
mainly formed by -sheets, which involves the zinc-ﬁnger domain
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Fig. 1. hHep1 production, puriﬁcation, functional and spectroscopic assays. (A) The picture depicts a SDS-PAGE 13.5% showing that hHep1 remains in the soluble fraction
after  cell lysis and that it was puriﬁed until homogeneity. (1) MM markers (left); (2) non-induced bacterial pellet; (3) induction bacterial pellet; (4) cell lysate pellet; (5) cell
lysate  supernatant, (6) eluate from the nickel afﬁnity chromatography; and (7) hHep1 after size exclusion chromatography. (B) hHep1 was able to maintain recombinant
human mortalin in the soluble fraction of the lysed cells. Mortalin was  expressed alone (lanes 2–5) and coexpressed with hHep1 (lanes 6–9) as described in Section 2. (1)
MM  markers (left); (2) non-induced bacterial pellet; (3) induction bacterial pellet; (4) cell lysate pellet; and (5) cell lysate supernatant; (6) non-induced bacterial pellet of the
coexpression; (7) induced bacterial pellet of the coexpression; (8) cell lysate pellet of the coexpression; (9) cell lysate supernatant of the coexpression. (C) hHep1 secondary
and  tertiary structures were analyzed by circular dichroism and intrinsic emission ﬂuorescence, respectively. Mean residue ellipticity [] spectra suggested that hHep1 is
mainly  formed by -sheet structure (see text for details). Inset: hHep1 intrinsic ﬂuorescence emission experiments were performed with 15 M of protein solved in the
TKP  buffer and excitation wavelength at 280 nm.  The spectra showed that the single Trp residue of hHep1 was  partially exposed to the solvent and exhibited max and 〈〉
of  336(1) nm and 344.7(0.1) nm,  respectively. In the presence of 6 M GndHCl, hHep1 showed max and 〈〉 of 350(1) nm and 354.2(0.3) nm,  respectively. Altogether, these
results  attested the production of hHep1 in both folded and functional state. (D) hHep1 (62–160) was  modeled using the Swiss-model program and the truncated yHep1
structure (PDB accession no 2E2Z) as template. The structure shows the position of the Trp115 (yellow) of the hHep1 and the zinc-ﬁnger domain where the Cys residues
which  form the zinc-ﬁnger motif are presented. The zinc ion is shown in blue.
as observed for yHep1. This data indicates that hHep1 and yHep1
share similarities in the secondary structure level, in spite of their
identity (25%) in the amino acid sequence (Fig. S1 – supplementary
material and [19]).
Intrinsic ﬂuorescence emission spectrophotometry was used to
obtain information on the local tertiary structure of hHep1, since
it has a single Trp115 residue, which was used as a ﬂuorescent
probe (Fig. S1 – supplementary material). Fig. 1C (inset) shows
the hHep1 (15 M)  ﬂuorescence emission spectra in native and
in denaturant conditions (6 M Gnd-HCl). The results showed that
hHep1, in native conditions, presents a max centered at 336(1)
nm and a 〈〉 of 344.7(0.1) nm.  In the presence of 6 M Gnd-HCl,
hHep1 presented max and 〈〉 centered at 350(1) and 354.2(0.3)
nm,  respectively, suggesting that it unfolded by 6 M Gnd-HCl. These
results indicated that hHep1 can exhibit the Trp115 residue par-
tially exposed to the solvent. The hHep1 homology model (Fig. 1D),
in spite of the low conﬁdence due to the low identity of hHep1
and the template yHep1, indicates that Trp115 is partially buried
between two -helices in the hHep1 C-terminal region, supporting
the experimental data. Overall, the puriﬁcation and spectroscopy
data suggest hHep1 was puriﬁed until homogeneity and at its
folded state.
3.3. Human Hep1 oligomerizes in a concentration-dependent
mode
We  studied the hydrodynamic properties of hHep1 using aSEC
technique (Fig. 2A). At 2 mg  mL−1 (∼135 M),  hHep1 showed an
elution proﬁle compatible with a MM of carbonic anhydrase, sug-
gesting that it could be a globular dimer. The experimental Rs
determined for hHep1 was of 22(1) Å (Fig. 2A, inset) and the the-
oretical Rs for a globular protein of 14.8 kDa (MM  of hHep1 as a
monomer) and 29.6 kDa (MM  of hHep1as a dimer) are of about
16 A˚ and 20 A˚, respectively (Table 1). Taken together, the aSEC data
observed for hHep1 suggest that it can be a globular dimer or an
asymmetric monomer. Similar results were observed for the trun-
cated forms of hHep1 [21].
In order to get further information on the hydrodynamic
and structural parameters of hHep1 in solution, we performed
sedimentation velocity AUC experiments with hHep1 in the con-
centration range of 0.15–2.5 mg  mL−1 (∼10–170 M).  Fig. 2B shows
the continuous c(S) distribution suggesting that hHep1 exhibits
one predominant species and, at least, 3 other species in solution
(Fig. 2B, inset). The predominant particle observed for hHep1 sed-
imentation velocity data provided a s020,w of 1.62(2) S (Fig. 2C)
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Fig. 2. hHep1 behaves as a mixture of monomers and oligomers species. (A) Analyt-
ical  SEC experiments showed that hHep1 eluate with an apparent MM of about
30  kDa as anhydrase carbonic did. Inset: the retention volume observed for the
standard proteins were transformed in the partial coefﬁcient kav (Eq. (2)) and plotted
against the Rs of the standard proteins. The arrow shows the partition coefﬁcient
of  hHep1 and corresponds to 22(1) Å. (B) The ﬁgure depicts the continuous c(S)
distributions in 2 protein concentrations where maximum of peaks resulted in
s20,w. At least 4 species could be observed in the c(S) distributions. Inset: zoom
in  the s20,w range 5–13 S showing the presence of peaks with higher s20,w-values.
(C) Figure depicts the plot of s20,w versus protein concentration of the four main
species observed in the sedimentation velocity data. All curves were ﬁtted by linear
regression in order to calculate s020,w for all four species observed (Table 1). The sed-
imentation velocity data suggest that hHep1 is the equilibrium of many oligomers
and that it undergoes oligomerization in a concentration-dependent manner (see
text  for details).
Table 1
Hydrodynamic properties of hHep1.
hHep1 hHep1 hydrodynamic properties
MM (kDa) Rs (Å) s020,w (S)
Predicted
Monomeric sphere 14.8 16 2.24
Dimeric sphere 29.6 20 3.55
aSEC 30(2) 22(1) –
Sedimentation velocity AUC experiments
1st species 15(1) – 1.62(0.02)
2nd species 57(6) – 3.9(0.2)
3rd species 170(20) – 8.0(0.3)
4th  species 290(20) – 10.9(0.3)
and the MM calculated by the SedFit software was  of about 15 kDa
(Table 1), suggesting that it is the monomeric form of hHep1. Based
on the s020,w and MM values estimated for other species present
in the hHep1 solution, the second species can be a tetramer with
a s020,w of 3.9(0.2) S and 57 kDa. The third species has a s020,w of
8.0(0.3) S and can be a decamer-dodecamer, while the forth species
(s020,w of 10.9(0.3) S) is a larger oligomer that can contain around
16–20 units of hHep1. Since there is a low quantity of these two
last species in solution, our data is unable to accurately deﬁne the
stoichiometry. It is worth mentioning that the f/f0, obtained by the
ratio of the s-value calculated for a spherical particle of 14.8 kDa
by the experimental s020,w-value of the smallest particle, was  of
around 1.4, hence suggesting that the monomeric form of hHep1 in
solution is slightly elongated. This observation is in agreement with
the solution structure solved for the truncated yHep1, which also
shows an asymmetric shape [22], and the modeled hHep1 structure
(Fig. 1D).
The sedimentation velocity data indicated that hHep1 as
monomer should be the main particle in solution. We  detected
that, at 150 g mL−1 (∼10 M),  hHep1 monomer is about 92–93%
of relative mass in solution, as observed in the relative area under
the c(S) curve ratio. Furthermore, it decreases to around 75% at
2.5 mg  mL−1 (∼170 M).  On the other hand, the relative amount
of the oligomers increases as a function of hHep1 concentration
(Fig. 3A). For instance, the amount of hHep1 as tetramer increased
from 5% at 150 g mL−1 to 16% at 2.5 mg mL−1, while the amount of
decamer-dodecamer increased from 2% up to 6% at the same pro-
tein concentration range. The larger oligomer was less than 1% of
the protein mass in the protein concentration range tested (data not
shown). These results indicated that the second and third species
concentrations increased 3-fold at the concentration range tested.
Interestingly, high NaCl concentrations (250–750 mM)  led to a
slight dissociation effect of the hHep1 oligomers. However, it did
not change the hHep1 c(S) distribution proﬁle since all 3 aforemen-
tioned oligomer forms remained present in solution, as observed
by AUC experiments (data not shown). Overall, the hydrodynamic
characterization experiments suggest that hHep1 oligomerizes in
a protein concentration mode.
We also studied hHep1 by means of SAXS technique, through
the forward scattering intensity value, I(0), which can provide the
MM,  if the sample is monodisperse [30]. However, it is not the
case of hHep1 based on the sedimentation velocity data. Thus, the
SAXS data are analyzed using the I(0)/cprot value, which can yield
interesting information on the protein aggregation state [31]. A
consistent increment of the I(0)/cprot value was observed with the
increasing protein concentration (Fig. 3B), indicating that hHep1
oligomerizes as a function of protein concentration. Furthermore,
one should bear in mind that the I(0)/cprot value can also indicate the
presence of interference effects over the SAXS curve. For instance,
one can infer that repulsive interference effects take place over
the SAXS curve if such value decreases as the protein concentra-
tion increases [32], which is not the case (data not shown). The
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Fig. 3. hHep1 oligomerizes in dependence of the concentration. (A) The relative amount of the three main hHep1 species in solution observed in the AUC experiments,
determined by the c(S) distribution data, as a function of the protein concentration. The relative amount of each species was estimated by the ratio of the area under curve
of  the peak of interest in the c(S) distribution curve by the sum of the area under curve of all peaks in the c(S) distribution curve. The data are presented in percentages. (B)
SAXS  experiments of hHep1 as a function of protein concentration. hHep1 sample was prepared in TKP buffer (in the absence and presence of 2 mM EDTA) and measured by
SAXS  in different concentrations of protein (from 1.7 to 8.6 mg  mL−1). The I(0) was  determined from the Guinier region of the scattering curve (using the plot LnI(0) versus
q2), in this case the I(0) is the linear coefﬁcient.
I(0)/cprot value increases from 0.028 up to 0.046 cm−1 mg−1 mL  for
1.5 and 8.5 mg  mL−1, respectively (Fig. 3B), it is almost a two-fold
increase in the I(0)/cprot value. The Rg, however, increases from 37 A˚
to 40 A˚ for 1.5 and 8.5 mg  mL−1, respectively (data not shown), indi-
cating that the monomeric species is probably predominant at this
concentration range.
Interestingly, in the presence of 2 mM EDTA, hHep1 also
exhibited the aforementioned oligomerization dependent on pro-
tein concentration; however this effect was less extensive and
suggested that some of the hHep1 oligomeric species may  be desta-
bilized by the presence of EDTA (Fig. 3B). In this case, the I(0)/cprot
value is kept unaltered up to ∼4 mg  mL−1, after which there this
value also increases, indicating that an oligomerization process
takes place over the SAXS curves (Fig. 3B).
We also measured the intrinsic ﬂuorescence emission spectra
and calculated the 〈〉-signal as a function of hHep1 concen-
tration (Fig. 4). The normalized hHep1 ﬂuorescence showed a
consistent blue shift when the protein concentration increased
from 5 M (74 g mL−1) to 50 M (740 g mL−1), and to 350 M
(5.2 mg  mL−1) (Fig. 4A). The 〈〉-signal as a function of hHep1
concentration also showed a consistent blue shift, in which the
〈〉-value decreased around 3 nm at the concentration range tested
and stabilized at around 300 M of hHep1 (Fig. 4B). Moreover,
these results promptly suggest that hHep1 oligomerization sur-
face should involve, to some extent, the participation of the Trp115
residue that becomes more protected from the solvent, as well as
the oligomerization of hHep1.
3.4. Zinc-ﬁnger domain of hHep1 has a structural stabilizing role
In order to understand the hHep1 structural organization we
performed urea-induced unfolding experiments followed by intrin-
sic ﬂuorescence emission (through 〈〉-signal). It should be noted
that the single Trp115 of the hHep1 construction is eleven amino
acids after the second hHep1 zinc-ﬁnger motif, which could report
events that involve the zinc-ﬁnger core (Fig. 1D). Human Hep1
chemical-induced unfolding monitored by ﬂuorescence was only
partially reversible (data not shown).
As here there was also the concern to evaluate the role of the zinc
ion on hHep1 structure, we performed chemical-induced unfol-
ding experiments in the absence and presence of 2 mM EDTA. It
was previously, we observed that titration of EDTA (1–100 mM)
Fig. 4. hHep1 oligomerization surface involves the Trp115. (A) Intrinsic emission
ﬂuorescence experiments at different hHep1 concentrations were performed with
hHep1 prepared in TKP buffer and excitation wavelength at 280 nm.  The normalized
intrinsic emission ﬂuorescence spectra show that hHep1 spectra exhibited a blue
shift  in the high protein concentration samples. (B) The calculated 〈〉 signals as
a  function of hHep1 concentration present a consistent blue shift. These results
suggest that hHep1 oligomerization involves the Trp115 region surface.
146 P.R. Dores-Silva et al. / International Journal of Biological Macromolecules 56 (2013) 140– 148
Fig. 5. Zinc ions play a stabilizing role in the hHep1 structure. (A) hHep1 urea-
induced unfolding experiments were performed using 15 M of protein in the
absence and presence of 2 mM EDTA (see Section 2 for more details) followed by 〈〉-
signal. In the absence of EDTA, hHep1 urea-induce unfolding was non-cooperative
or  gradual, suggesting the presence of unfolding intermediates. In the presence of
2  mM EDTA, we observed a shift of the curve to lower urea concentrations, suggest-
ing  that EDTA disturbed the stability of the zinc-ﬁnger core of hHep1 by chelating
the  zinc ions. (B) Thermal-induced unfolding followed by DSC experiments of hHep1
in  the absence and presence of 2 mM EDTA. Human Hep1 presented a main unfol-
ding transition centered at 74 ◦C and a shoulder at 50 ◦C. In the presence of 2 mM
EDTA, the main unfolding transition was reduced to 69 ◦C suggesting that the Zn2+
chelating by EDTA destabilized the hHep1 structure. No signiﬁcant changes were
in the hHep1 solutions did not induce changes in the 〈〉-signal
(Fig. S2 – supplementary material). Fig. 5A depicts 〈〉-signal of
hHep1 (at 15 M)  as a function of urea concentration, which show
that urea-induced unfolding experiments did not lead hHep1 to
the full unfolding. When the same experiment was carried out
with Gnd-HCl as chemical denaturant, the 〈〉-signal reached values
higher than 9 M urea (Fig. S3 – supplementary material). This result
suggests that hHep1 has high structural stability on urea-induced
unfolding.
Fig. 5A also shows that hHep1 urea-induced unfolding had an
uncooperative or gradual unfolding proﬁle with no clear transition.
When we performed this experiment in the presence of 2 mM EDTA,
the gradual transition remained at low urea concentrations, but a
more deﬁned transition centered at 3.9 (0.1) M urea was observed.
This result suggests that EDTA affected the structure of hHep1,
probably by chelating zinc ions and removing them from hHep1
structure, as well as the unfolding of the protein. Thus, urea and
2 mM EDTA had synergistic effects on inducing hHep1 to unfold.
Furthermore, the transition centered at 3.9 M urea is the zinc ﬁnger
core unfolding. The gradual proﬁle observed at low urea concentra-
tions involves the unfolding of some protein region leading to the
formation of an unfolding intermediate, consisted by the zinc ﬁn-
ger core of hHep1. On the other hand, the hHep1 region, which
unfolds at low urea concentration, probably involves the participa-
tion of the Trp115 residue. The hHep1 homology model (Fig. 1D)
shows that the Trp115 is located between 2 -helices, suggesting
that they could be the hHep1 structural elements that unfold at low
urea concentration.
The chemical-induced unfolding experiments using Gnd-HCl as
denaturant evidenced the same effect observed for urea in the pres-
ence and absence of EDTA, where in the presence of EDTA the
unfolding curve changed to lower denaturant concentration (Fig.
S3 – supplementary material). Therefore, zinc ion has a structural
impact on the stabilization of hHep1.
Differential scanning calorimetry experiments were performed
in order to conﬁrm that zinc ion has a stabilizing effect on the struc-
ture of hHep1 (Fig. 5B). In the absence of EDTA, a main transition
centered at 74 ◦C was observed, which was attributed to the unfol-
ding of the zinc-ﬁnger core, since it was affected by the presence
of 2 mM EDTA. The presence of the divalent ion chelating agent led
hHep1 to unfold thermally with a transition centered at 69 ◦C, about
5 ◦C less than in the absence of EDTA. These results conﬁrm that
zinc ion acts by stabilizing the hHep1 structure. In both cases, the
thermal-induced unfolding was  irreversible, and the curve ﬁtting to
extract the apparent enthalpy change of the transition was  not per-
formed. Moreover, a transition centered at 50 ◦C was  also observed
in both thermograms. This unfolding transition was  attributed to
the ﬁrst unfolding event, as also seen in the urea-induced unfolding
followed by ﬂuorescence, which was not disturbed by the presence
of 2 mM EDTA.
Moreover, urea-induced experiments of hHep1 at 3.5 mg  mL−1
in the absence and presence of 2 mM EDTA were also monitored
by means of SAXS. As hHep1 solutions are a mixture of several
oligomeric species, SAXS signal and parameters like MM and Rg
depend on the sum of the contribution of each species in solu-
tion. As it is not possible to deﬁne the scattering contribution
observed in the shoulder centered at 50 ◦C which should be related to the unfol-
ding intermediates. (C) Weighted-average Rg determined by Guinier’s law (inset) of
hHep1 (at 3.5 mg  mL−1) as a function of urea concentration (0 to 6 M) in the absence
and presence of 2 mM EDTA. The range of q2 used to calculate the weighted-average
Rg was of 0.00026–0.00084 A˚−1, consistent with the validity of Guinier’s law, i.e.,
for  qmax.Rg < 1.3. The curves show a dual effect where ﬁrst the weighted-average Rg
reduces due to the dissociation of the oligomers, and after it increases due to hHep1
unfolding. In the presence of 2 mM EDTA, hHep1 reached its unfolded state earlier
than in its absence.
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of each species in solution, we cannot apply shape reconstruc-
tion modeling based on the particle scattering pattern. However,
when we monitored a weighted-average Rg (determined from the
Guinier’s Law [33]) as a function of urea concentration, a dual
behavior was  observed: (a) an initial and consistent decrease of
the weighted-average Rg up to 4 M urea and, (b) an increment of
the weighted-average Rg between 4–6 M Urea (Fig. 5C). In pres-
ence of 2 mM EDTA, hHep1 urea-induced unfolding also showed a
similar effect, but the initial reduction of the weighted-average Rg-
value was observed up to 2 M urea, followed by the increment at
higher urea concentrations. Thus, the presence of EDTA led hHep1
to unfold at smaller urea concentrations in agreement with the
urea-induced unfolding experiments (Fig. 5A).
The aforementioned dual effect can be explained by the pres-
ence of oligomers in the hHep1 solution. The initial decrease of
the weighted-average Rg-values involves the dissociation of hHep1
oligomers, concomitant with the unfolding of hHep1 to the inter-
mediate at 2 M urea. This interpretation is consistent with the
gradual transition observed in the urea-induced experiments fol-
lowed by ﬂuorescence (Fig. 5A), and with the dependence on
〈〉-signal with protein concentration (Fig. 4). At higher urea con-
centration (i.e.,>4 M),  the hHep1 zinc-ﬁnger core unfolds, resulting
in an increment of the weighted-average Rg-values, as shown ear-
lier [34], since it was susceptible to the presence of EDTA.
On the whole, the results presented here indicate that the zinc
ion acts by stabilizing the hHep1 structure and is in line with the
functional results. It was shown that modiﬁcations in the zinc ﬁn-
ger motifs of yHep1 resulted in defective growth in yeast [17], and
the dependence on the zinc ﬁnger domain for the proper hHep1
function [21].
4. Concluding remarks
The mitochondrial molecular chaperones, coordinated by
mtHsp70, play a key role in the mitochondrial protein import
system, since it is the motor that drives the preprotein import
process and assists the folding of imported proteins. However, sev-
eral mtHsp70 are prone to self-aggregation in vivo and in vitro,
which limits their study. Similar to other Hsp70s, mtHsp70s are
assisted by many co-chaperones [6,35],  with Hep1 being described
as an essential mitochondrial co-chaperone. One of the functions of
Hep1 is blocking the self-aggregation process of mtHsp70, enabling
their maintenance in solution. As shown for other mtHsp70 (and
here), recombinant human mortalin depends on hHep1 for soluble
expression in E. coli cells [18,19,21].  The human mortalin and hHep1
coexpression strategy allows mortalin production and puriﬁcation
as a monomer (data not shown), which will allow future structure-
function characterization of mortalin.
Little is known about the structure-function of hHep1. Thus,
the goal of this study was to produce the recombinant hHep1 for
structure-function characterization. Recombinant hHep1 was puri-
ﬁed until homogeneity in the folded state, exhibiting -sheets as it
main secondary structure content, which is in agreement with the
molecular homology model built (Fig. 1D).
As observed by AUC and SAXS experiments, hHep1 oligomer-
izes in dependence on the protein concentration. Hydrodynamic
characterization strongly suggested that hHep1 is a mixture of at
least three oligomeric species in equilibrium with the monomer.
Furthermore, the monomer is the main species in solution, at least
at the range of hHep1 concentration studied. However, it remains
an open question if hHep1 oligomeric species are essential for its
biological function as a co-chaperone of mortalin or mitochondria
genesis. The relationship of intrinsic ﬂuorescence emission sig-
nal with protein concentration indicates that the oligomerization
surface can involve the Trp115 surface region of the hHep1 struc-
ture. In fact, Trp115 seems to be protected from the solvent during
oligomerization process (Fig. 4). The hHep1 molecular homology
model (Fig. 1D) indicates that Trp115 is partially buried between
the two -helices on the C-terminal, thus we can speculate that
these structural elements could be involved in the hHep1 oligome-
rization process.
Human Hep1 is a zinc-ﬁnger protein, as observed for ortholog
proteins [16,17,21,22].  In order to analyze the structural impor-
tance of the zinc ion for hHep1, we  performed chemical- and
thermal-induced unfolding experiments in the absence and pres-
ence of 2 mM EDTA. In all experiments, hHep1 was less stable in the
presence of EDTA, suggesting that zinc ion plays a structural role in
stabilizing the hHep1.
In sum, the results presented here suggest that, despite the
apparent simplicity due to size and function, hHep1 presents a sur-
prising structural behavior and complexity. We also observed that
hHep1 shares some structural similarities (secondary structure and
monomer’s hydrodynamic shape) with the yeast ortholog despite
their low identity and functional differences. Further studies must
consider the role of the hHep1 oligomerization for its functionality
in mortalin regulation and aggregation avoidance.
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